TA
ANIK icon

Teachers Advisors’s Anika Therapeutics ANIK Stock Holding History

Teachers Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$911K Buy
30,129
+2,247
+8% +$77K ﹤0.01% 2334
2018
Q4 		$937K Sell
27,882
-202
-0.7% -$7.29K ﹤0.01% 2222
2018
Q3 		$1.19M Buy
28,084
+1,802
+7% +$71.2K ﹤0.01% 2235
2018
Q2 		$841K Hold
26,282
– – ﹤0.01% 2422
2018
Q1 		$1.31M Sell
26,282
-143,656
-85% -$8.12M ﹤0.01% 2088
2017
Q4 		$9.16M Sell
169,938
-1,250
-0.7% -$69.2K 0.01% 1077
2017
Q3 		$9.93M Sell
171,188
-100
-0.1% -$5.23K 0.01% 1027
2017
Q2 		$8.45M Buy
171,288
+2,211
+1% +$102K 0.01% 1081
2017
Q1 		$7.34M Buy
169,077
+1,061
+0.6% +$50.7K 0.01% 1119
2016
Q4 		$8.23M Buy
168,016
+120
+0.1% +$5.55K 0.01% 1040
2016
Q3 		$8.03M Buy
167,896
+5,600
+3% +$277K 0.01% 1030
2016
Q2 		$8.71M Buy
162,296
+1,899
+1% +$89.5K 0.02% 936
2016
Q1 		$7.17M Buy
160,397
+7,500
+5% +$304K 0.01% 1002
2015
Q4 		$5.83M Hold
152,897
– – 0.01% 1083
2015
Q3 		$4.87M Buy
152,897
+160
+0.1% +$5.58K 0.01% 1126
2015
Q2 		$5.04M Buy
152,737
+15,593
+11% +$556K 0.01% 1166
2015
Q1 		$5.65M Buy
137,144
+12,900
+10% +$522K 0.01% 1116
2014
Q4 		$5.06M Buy
124,244
+15,627
+14% +$611K 0.01% 1140
2014
Q3 		$3.98M Buy
108,617
+20,500
+23% +$886K 0.01% 1216
2014
Q2 		$4.08M Buy
88,117
+69,563
+375% +$3.09M 0.01% 1210
2014
Q1 		$763K Hold
18,554
– – ﹤0.01% 2179
2013
Q4 		$708K Hold
18,554
– – ﹤0.01% 2188
2013
Q3 		$445K Buy
18,554
+175
+1% +$3.93K ﹤0.01% 2388
2013
Q2 		$312K Buy
+18,379
New +$265K ﹤0.01% 2522

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Teachers Advisors's ANIK Position: Q1 2019 in Review

Teachers Advisors increased its Anika Therapeutics (ANIK) stake by 8.1% in Q1 2019, buying an estimated $77K and bringing the position to 30,129 shares worth $911K. The position accounts for ﹤0.01% of the portfolio, ranked #2334.

Teachers Advisors first reported a position in ANIK in Q2 2013 and has held it in 24 quarters since. The position peaked at $9.93M in Q3 2017. 157 funds tracked by Wall St. Rank hold ANIK as of Q1 2019.

  • Teachers Advisors held 30,129 shares of Anika Therapeutics worth $911K as of Q1 2019.
  • Teachers Advisors bought 2,247 Anika Therapeutics shares in Q1 2019, an estimated $77K.
  • Anika Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2334 holding.
  • Teachers Advisors first reported a position in Anika Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Anika Therapeutics position peaked at $9.93M in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.